Last reviewed · How we verify

NCT03501446: ELVIS

A Pilot Validation Study of Continuous CO2-based End-expiratory Lung Volume Measurements in Humans.

Completed Last updated 18 April 2018
What this trial tests

trial in Ventilator Lung in 23 participants. Completed in 21 October 2015.

Timeline
1 December 2014
Primary endpoint
21 October 2015
21 October 2015

Quick facts

Lead sponsorKarolinska Institutet
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date1 December 2014
Primary completion21 October 2015
Estimated completion21 October 2015
Sites1 location across Sweden

Conditions studied

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Ventilator Lung or Gas Exchange. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The capnodynamic method non-invasively calculates effective lung volume (ELV) continuously during surgery. In this study ELV is compared to functionalresidual capacity (FRC) measured with Nitrogen Multiple Breath Wash out (NMBW) at 0 and 5 cm H2O Positive End Expiratory Pressure (PEEP) in patients scheduled for neck surgery at the Karolinska University Hospital, Solna, Sweden.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventilator Lung

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03501446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing